Evogene Ltd

NASDAQ:EVGN  
0.75
-0.03 (-3.83%)
Earnings Announcements

Evogene Reports First Quarter 2022 Financial Results

Published: 05/26/2022 11:16 GMT
Evogene Ltd (EVGN) - Evogene Reports First Quarter 2022 Financial Results.
Q1 Revenue $237,000 Versus $333,000.
Net Loss for Quarter Was $9.1 Million.
Qtrly Basic and Diluted Loss per Share, Attributable to Equity Holders of Company $0.20.
Revenue is expected to be $0.22 Million
Adjusted EPS is expected to be -$0.19

Next Quarter Revenue Guidance is expected to be $0.52 Million
Next Quarter EPS Guidance is expected to be -$0.20

More details on our Analysts Page.